Skip to Main Content

Paper Details

Mesenchymal stem cells and connective tissue diseases: From bench to bedside.
J Transl Int Med
2
2022
CTD, CTDs, IIM, MSC, MSCs, Mesenchymal, Mesenchymal stem cells, RA, SLE, SSc, connective tissue diseases, idiopathic inflammatory myopathies, immune cells, immune-mediated disorders, mesenchymal, mesenchymal stem cells, pSS, patients, primary Sjgren's syndrome, rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis
Author NameAffiliation
Nan JiangDepartment of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital (PUMCH), Chinese Academy of Medical Sciences & Peking Union Medical College National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology State Key Laboratory of Complex Severe and Rare Diseases Key Laboratory of Rheumatology and Clinical Immunology
Xinping TianDepartment of Rheumatology and Clinical Immunology, Peking Union Medical College Hospital (PUMCH), Chinese Academy of Medical Sciences & Peking Union Medical College National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science & Technology State Key Laboratory of Complex Severe and Rare Diseases Key Laboratory of Rheumatology and Clinical Immunology
  • 1 - 2

Datasets

Release 1.2